Tinostamustine: A Novel Alkylator – First Data in Glioblastoma
Time: 10:00 am
day: Conference Day One
Details:
- Introducing Tinostamustine as a glioblastoma therapeutic
- Analyzing the development program and preliminary results of MDACC Phase I IIT
- Testing tinostamustine in a Phase I GBM study in Europe
